Trial now
PIPELINE

High-Grade Debt Issuance

USDCAD TECHS

Bulls Remain In Charge

AUDUSD TECHS

Southbound

Sign up now for free access to this content.

Please enter your details below and select your areas of interest.

Latest tracker polling from YouGov shows that a month after the widespread coverage of an extremely rare blood clotting issue in relation to the AstraZeneca COVID-19 vaccine, trust for the jab in Germany and France remains low. In Denmark trust has also collapsed following the gov'ts permanent halt to the vaccine's rollout there.

  • AstraZeneca: UK: 78% safe (+1 from mid-Mar), Spain: 54% (+16), Italy: 48% (+12), Sweden: 44% (+1), Germany: 34% (+2), Denmark: 25% (-17), France: 22% (-1). Fieldwork 13-22 Apr.

Public trust in Europe is uniformly higher for those vaccines that have been rolled out most in each respective country, with the Pfizer/BioNTech and Moderna vaccines scoring well in highly-vaccinated states such as Denmark, Italy and Spain:

  • Pfizer/BioNTech: Denmark: 81% safe (+5 from mid-Mar), UK: 80% safe (+1 from mid-Mar), Spain: 77% (+3), Italy: 76% (+7), Sweden: 70% (+9), Germany: 69% (+3), France: 56% (+5). Fieldwork 13-22 Apr.
  • Moderna: Spain: 72% safe (+4 from mid-Mar), Denmark: 68% (+4), Italy: 66% (+10), Sweden: 63% (+7), UK: 63% safe (+13), Germany: 57% (+2), France: 47% (+8). Fieldwork 13-22 Apr.

There is also uniformly low trust in the Russian Sputnik V vaccine, although it is somewhat higher in Italy, Spain and Germany, where their gov'ts have spoken about securing doses outside the EU's purchase scheme if/when it is approved by the EMA:

  • Sputnik V: Italy: 41% safe, Spain: 41%, Germany: 30%, Sweden: 23%, UK: 19%, France: 17%, Denmark: 12%. Fieldwork 13-22 Apr.